XML 69 R55.htm IDEA: XBRL DOCUMENT v3.24.2.u1
SCHEDULE OF OPERATIONS, ASSETS AND CAPITAL EXPENDITURES FOR OUR BUSINESS SEGMENTS (Details) - USD ($)
 3 Months Ended 6 Months Ended
Jun. 30, 2024
Mar. 31, 2024
Jun. 30, 2023
Mar. 31, 2023
Jun. 30, 2024
Jun. 30, 2023
Segment Reporting Information [Line Items]            
Net revenue $ 20,158,823   $ 15,753,164   $ 38,695,461 $ 31,275,081
Gross profit 18,150,137   13,565,648   34,796,729 26,961,906
Selling, general and administrative expenses 18,957,608   13,811,476   35,149,867 26,780,545
Research and development 985,651   1,177,128   1,931,949 2,494,452
Depreciation and amortization 1,105,507   803,694   2,210,927 1,582,569
Interest expense (644,346)     (911,682) (6)
Net loss (3,529,202) $ (1,799,043) (1,866,180) $ (1,216,329) (5,328,245) (3,082,509)
Segment EBITDA 592,181   (295,624)   903,602 (588,454)
Segment assets (at period end) [1] 73,383,605   73,871,149   73,383,605 73,871,149
Expenditures for long-lived assets 58,762   12,945   124,580 40,650
Segment EBITDA 592,181   (295,624)   903,602 (588,454)
Interest expense 644,346     911,682 6
Noncash share-based compensation 1,082,750   1,127,332   2,214,931 1,724,637
Change in fair value of earnout liabilities (13,773)   (360,470)   (79,451) (813,157)
Executive separation costs [2] 904,780     904,780
Acquisition costs 397,773     397,773
Noncash share-based compensation         1,886,136 1,724,637
Share based compensation related to executive separation costs         328,795  
Sanara Surgical [Member]            
Segment Reporting Information [Line Items]            
Net revenue 20,158,823   15,753,164   38,695,461 31,272,351
Gross profit 18,150,137   13,565,648   34,796,729 26,968,141
Selling, general and administrative expenses 18,349,924   13,301,230   34,032,964 25,768,626
Research and development 582,443   208,727   1,161,424 443,963
Depreciation and amortization 698,407   396,597   1,396,908 768,616
Interest expense (644,346)     (911,682) (6)
Net loss (2,214,313)   95,098   (2,691,798) 614,061
Segment EBITDA 1,393,959   1,120,207   2,532,145 2,365,280
Segment assets (at period end) [1] 51,469,137   51,147,589   51,469,137 51,147,589
Expenditures for long-lived assets 58,762   12,945   124,580 40,650
Segment EBITDA 1,393,959   1,120,207   2,532,145 2,365,280
Interest expense 644,346     911,682 6
Noncash share-based compensation 1,046,321   1,064,516      
Change in fair value of earnout liabilities 89,330   (436,004)   (14,451) (627,132)
Executive separation costs [2] 904,780     904,780
Acquisition costs 225,088     225,088
Noncash share-based compensation         1,799,936 1,609,729
THP [Member]            
Segment Reporting Information [Line Items]            
Net revenue     2,730
Gross profit     (6,235)
Selling, general and administrative expenses 607,684   510,246   1,116,903 1,011,919
Research and development 403,208   968,401   770,525 2,050,489
Depreciation and amortization 407,100   407,097   814,019 813,953
Interest expense    
Net loss (1,314,889)   (1,961,278)   (2,636,447) (3,696,570)
Segment EBITDA (801,778)   (1,415,831)   (1,628,543) (2,953,734)
Segment assets (at period end) [1] 21,914,468   22,723,560   21,914,468 22,723,560
Expenditures for long-lived assets    
Segment EBITDA (801,778)   (1,415,831)   (1,628,543) (2,953,734)
Interest expense    
Noncash share-based compensation 36,429   62,816      
Change in fair value of earnout liabilities (103,103)   75,534   (65,000) (186,025)
Executive separation costs [2]    
Acquisition costs $ 172,685     172,685
Noncash share-based compensation         $ 86,200 $ 114,908
[1] - Segment assets for 2023 represent assets as of 12.31.23.
[2] - Includes $328,795 of share-based compensation related to executive separation costs.